Actively Recruiting
Led by China National Center for Cardiovascular Diseases · Updated on 2025-12-08
536
Participants Needed
1
Research Sites
8 weeks
Total Duration
C
China National Center for Cardiovascular Diseases
Lead Sponsor
C
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborating Sponsor
Researchers are evaluating an AI-assisted digital health tool called the "Smart family doctor" to improve control of hypertension, diabetes, and dyslipidemia in adults who have undergone coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). This study uses a randomized controlled design involving about 536 participants across 5-10 hospitals. Participants must be adults aged 18 or older with a history of CABG or PCI and the specified conditions. Participants in the experimental group will use the AI-assisted "Smart family doctor" app that provides personalized health education, targeted guidance on managing blood pressure, blood sugar, medication adherence, exercise, and smoking cessation. They will also receive tailored reminders and can report self-measured health data for feedback. Both groups receive weekly 3-hour health management guidance from health managers, and participants will wear a smart band daily for health data collection during the 6-month study period. Throughout the study, participants will be assessed for control rates of hypertension, diabetes, and hyperlipidemia at 6 months. Additional measures include blood pressure, cholesterol levels, blood glucose, physical activity, quality of life, psychological status, and cognitive function. The study monitors health data continuously via smart bands and collects self-reports and clinical assessments to evaluate the intervention's impact over the 6 months.
CONDITIONS
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive health management guidance from a health manager once a week and, if assigned to the experimental group, use the "Smart family doctor" AI-assisted application for personalized disease management. Participants wear a smart band daily to collect health data during the study.
Weekly visits for up to 6 months
Total: 1 location
1
Xinjiang's First Affiliated Hospital of medical university
Ürümqi, Xinjiang, China, 102300
Actively Recruiting
L
Lihua Zhang Zhang, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Lubi Lei, Jingkuo Li, Lihua Zhang...
https://pubmed.ncbi.nlm.nih.gov/41218945